Hill, B. T., Roth, C. J., Kositsky, R., Dave, T., Love, C., McKinney, M., … Dave, S. S. (2021). Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy. In BLOOD (Vol. 138).

Hill, Brian T., Caroline J. Roth, Rachel Kositsky, Tushar Dave, Cassandra Love, Matthew McKinney, Ahmed Galal, et al. “Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy.” In BLOOD, Vol. 138, 2021.

Hill BT, Roth CJ, Kositsky R, Dave T, Love C, McKinney M, et al. Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy. In: BLOOD. 2021.

Hill, Brian T., et al. “Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy.” BLOOD, vol. 138, 2021.

Hill BT, Roth CJ, Kositsky R, Dave T, Love C, McKinney M, Galal A, Neff JL, Mian A, Kendall E, Ondrejka SL, Chiaramonte M, Bhagat G, Ofori K, Reshef R, Kovach AE, Sethi T, Mason EF, Bhaskar S, Oluwole OO, Pallas C, Ghosh N, Ferdman R, Chen GL, Hernandez-Ilizaliturri FJ, Zurko JC, Cunningham A, Shah NN, Hu B, Stephens DM, Ghosh M, Bailey N, Patel K, Pagel JM, Kannan KK, Hsi ED, Vaidya R, Ip A, Goy AH, Kambhampati S, Ohgami RS, Andreadis C, Thacker E, Rozzi C, Parker C, Happ L, Dave SS. Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy. BLOOD. 2021.